The three discrete reforms give the Commonwealth, through the TGA and the Health Department Secretary, greater capacity to demand information, classify biologicals in groups, and exercise warrantless enforcement powers at clinical trial sites.
A three-pronged expansion of Commonwealth reach in therapeutic-goods regulation
September 4, 2026 Latest NewsBioPharma
Latest Video
New Stories
-
Australia secures sovereign viral vector manufacturing as VVMF wins TGA licence
September 10, 2026 - - Latest News -
Which is it? The two perspectives on patient input compounded by the lack of transparency
September 10, 2026 - - Latest News -
Melbourne oncologist takes the reins at Australia's private cancer physicians body
September 10, 2026 - -
Artificial intelligence in HTA has arrived, kind of, but nobody was thinking of this
September 10, 2026 - - Latest News -
Guilt over this enduring failure is the correct response
September 9, 2026 - - Latest News -
Poweroos chase world title in Argentina with new backing from Biogen
September 9, 2026 - - Latest News -
What will AI be capable of in two months? We don't know, and that's the point
September 9, 2026 - - Latest News
